SRX Health Solutions, Inc. (SRXH) is a publicly traded Healthcare sector company. As of May 21, 2026, SRXH trades at $0.12 with a market cap of $68.61M and a P/E ratio of -0.06. SRXH moved +2.87% today. Year to date, SRXH is -42.23%; over the trailing twelve months it is -82.41%. Its 52-week range spans $0.08 to $2.02. Rallies surfaces SRXH's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
SRx Health Solutions to Distribute 75% Profits from Astro Investment XVII SPV: SRx Health Solutions’ board approved distribution of 75% of profits from its stake in Astro Investment XVII, a special purpose vehicle holding SpaceX and other AI and space assets. The company previously committed over 10% of its investable capital to this SPV and will return capital to shareholders upon wind-down.
| Metric | Value |
|---|---|
| Price | $0.12 |
| Market Cap | $68.61M |
| P/E Ratio | -0.06 |
| EPS | $-2.13 |
| Dividend Yield | 0.00% |
| 52-Week High | $2.02 |
| 52-Week Low | $0.08 |
| Volume | 875.29K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-8.64M |
| Gross Margin | 0.00% |
SRXH analyst coverage data. Average price target: $0.00.